Cargando…

Host-cell recognition of SARS-CoV-2 spike receptor binding domain from different variants

Detalles Bibliográficos
Autores principales:	Elfiky, Abdo A, Ibrahim, Ibrahim M, Ibrahim, Mohamed N, Elshemey, Wael M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547754/ https://www.ncbi.nlm.nih.gov/pubmed/36220503 http://dx.doi.org/10.1016/j.jinf.2022.10.009

Ejemplares similares

Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico
por: Elfiky, Abdo A, et al.
Publicado: (2021)

Host-cell recognition through Cs-GRP78 is enhanced in the new Omicron variant of SARS-CoV-2, in silico structural point of view
por: Elfiky, Abdo A, et al.
Publicado: (2022)

Interference of Chaga mushroom terpenoids with the attachment of SARS-CoV-2; in silico perspective
por: Elshemey, Wael M., et al.
Publicado: (2022)

Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase
por: Elfiky, Abdo A., et al.
Publicado: (2022)

A possible role for GRP78 in cross vaccination against COVID-19
por: Elfiky, Abdo A., et al.
Publicado: (2021)

Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective
por: Sonousi, Amr, et al.
Publicado: (2021)

COVID-19 spike-host cell receptor GRP78 binding site prediction
por: Ibrahim, Ibrahim M., et al.
Publicado: (2020)

SARS-CoV-2 Delta Variant is Recognized Through GRP78 Host-Cell Surface Receptor, In Silico Perspective
por: Elfiky, Abdo A., et al.
Publicado: (2022)

Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective
por: Ibrahim, Ibrahim M., et al.
Publicado: (2021)

IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study
por: Elfiky, Abdo A., et al.
Publicado: (2016)

SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses
por: Elfiky, Abdo A.
Publicado: (2020)

Targeting SARS-CoV-2 endoribonuclease: a structure-based virtual screening supported by in vitro analysis
por: Ibrahim, Ibrahim M., et al.
Publicado: (2022)

The value of electrostatic potentials of the spike receptor binding and N-terminal domains in addressing transmissibility and infectivity of SARS-CoV-2 variants of concern
por: Pascarella, Stefano, et al.
Publicado: (2022)

SARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic
por: Ismail, Alaa M., et al.
Publicado: (2020)

Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases
por: Rossi, Giovanni A., et al.
Publicado: (2020)

Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition
por: Greaney, Allison J., et al.
Publicado: (2020)

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
por: Greaney, Allison J., et al.
Publicado: (2021)

Emergence of novel combinations of SARS-CoV-2 spike receptor binding domain variants in Senegal
por: Ahouidi, Ambroise D., et al.
Publicado: (2021)

Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (M(pro)) inhibitors to unveil a hope against COVID-19
por: Adem, Şevki, et al.
Publicado: (2022)

Ebola virus glycoprotein GP1—host cell-surface HSPA5 binding site prediction
por: Elfiky, Abdo A.
Publicado: (2020)

Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein
por: Verma, Saroj, et al.
Publicado: (2022)

How helpful were molecular dynamics simulations in shaping our understanding of SARS-CoV-2 spike protein dynamics?
por: Abduljalil, Jameel M., et al.
Publicado: (2023)

The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein
por: Dokainish, Hisham M, et al.
Publicado: (2022)

Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an in silico perspective
por: Ogunyemi, Oludare M, et al.
Publicado: (2020)

SARS-CoV-2 beta variant substitutions alter spike glycoprotein receptor binding domain structure and stability
por: Moss, Daniel L., et al.
Publicado: (2021)

Display of receptor-binding domain of SARS-CoV-2 Spike protein variants on the Saccharomyces cerevisiae cell surface
por: Xing, Hongguan, et al.
Publicado: (2022)

Correlating the differences in the receptor binding domain of SARS-CoV-2 spike variants on their interactions with human ACE2 receptor
por: Mahalingam, Gokulnath, et al.
Publicado: (2023)

GRP78: A cell's response to stress
por: Ibrahim, Ibrahim M., et al.
Publicado: (2019)

Identifying zoonotic origin of SARS-CoV-2 by modeling the binding affinity between Spike receptor-binding domain and host ACE2
por: Huang, Xiaoqiang, et al.
Publicado: (2020)

Glycans on the SARS-CoV-2 Spike Control the Receptor Binding Domain Conformation
por: Henderson, Rory, et al.
Publicado: (2020)

Conformational Dynamics of the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
por: Mamchur, Aleksandra A., et al.
Publicado: (2022)

Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19
por: Adem, Şevki, et al.
Publicado: (2021)

Spike protein receptor-binding domains from SARS-CoV-2 variants of interest bind human ACE2 more tightly than the prototype spike protein
por: Charles, Jermilia, et al.
Publicado: (2023)

Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain
por: Antonopoulos, Aristotelis, et al.
Publicado: (2020)

Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective
por: Elfiky, Abdo A
Publicado: (2022)

Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies
por: Yuan, Meng, et al.
Publicado: (2021)

Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC
por: Du, Lanying, et al.
Publicado: (2013)

Sphingosine prevents binding of SARS–CoV-2 spike to its cellular receptor ACE2
por: Edwards, Michael J., et al.
Publicado: (2020)

Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
por: Chi, Xiaojing, et al.
Publicado: (2020)

Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants
por: Yin, Rui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_luu77klvk634n1opmv502nalmh